BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 9444882)

  • 1. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization.
    Snider RH; Nylen ES; Becker KL
    J Investig Med; 1997 Dec; 45(9):552-60. PubMed ID: 9444882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum calcitonin precursors in sepsis and systemic inflammation.
    Whang KT; Steinwald PM; White JC; Nylen ES; Snider RH; Simon GL; Goldberg RL; Becker KL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3296-301. PubMed ID: 9745444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations.
    Becker KL; Snider R; Nylen ES
    Crit Care Med; 2008 Mar; 36(3):941-52. PubMed ID: 18431284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of chromogranin A and calcitonin precursors measurements for the discrimination of ectopic ACTH secretion from Cushing's disease.
    Zemskova MS; Nylen ES; Patronas NJ; Oldfield EH; Becker KL; Nieman LK
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2962-5. PubMed ID: 19470624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma.
    Ittner L; Born W; Rau B; Steinbach G; Fischer JA
    Eur J Endocrinol; 2002 Dec; 147(6):727-31. PubMed ID: 12457446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late immunoneutralization of procalcitonin arrests the progression of lethal porcine sepsis.
    Martinez JM; Wagner KE; Snider RH; Nylen ES; Muller B; Sarani B; Becker KL; White JC
    Surg Infect (Larchmt); 2001; 2(3):193-202; discussion 202-3. PubMed ID: 12593709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.
    Becker KL; Snider R; Nylen ES
    Br J Pharmacol; 2010 Jan; 159(2):253-64. PubMed ID: 20002097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of procalcitonin levels in patients with systemic inflammatory response syndrome as the diagnosis of infection and the severity of illness].
    Endo S; Kasai T; Inada K
    Kansenshogaku Zasshi; 1999 Mar; 73(3):197-204. PubMed ID: 10222664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neuroendocrine peptide derived from the amino-terminal half of rat procalcitonin.
    Burns DM; Birnbaum RS; Roos BA
    Mol Endocrinol; 1989 Jan; 3(1):140-7. PubMed ID: 2915645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoneutralization of procalcitonin or its component peptides: a promising treatment of sepsis.
    Becker KL
    Clin Sci (Lond); 2010 Dec; 119(12):515-7. PubMed ID: 20649514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Procalcitonin as a diagnostic marker in systemic inflammatory response syndrome (SIRS) and sepsis].
    Hryckiewicz K; Juszczyk J; Samet A; Arłukowicz E; Sledzińska A; Bolewska B
    Przegl Epidemiol; 2006; 60(1):7-15. PubMed ID: 16758733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin has bioactivity at calcitonin receptor family complexes: potential mediator implications in sepsis.
    Sexton PM; Christopoulos G; Christopoulos A; Nylen ES; Snider RH; Becker KL
    Crit Care Med; 2008 May; 36(5):1637-40. PubMed ID: 18434892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of procalcitonin: the influence of cardiopulmonary bypass, aprotinin, SIRS, and sepsis.
    Boeken U; Feindt P; Petzold T; Klein M; Micek M; Seyfert UT; Mohan E; Schulte HD; Gams E
    Thorac Cardiovasc Surg; 1998 Dec; 46(6):348-51. PubMed ID: 9928856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumonitis-associated hyperprocalcitoninemia.
    Nylén ES; Snider RH; Thompson KA; Rohatgi P; Becker KL
    Am J Med Sci; 1996 Jul; 312(1):12-8. PubMed ID: 8686724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.
    Nylen ES; Whang KT; Snider RH; Steinwald PM; White JC; Becker KL
    Crit Care Med; 1998 Jun; 26(6):1001-6. PubMed ID: 9635646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathfast presepsin assay for early diagnosis of systemic inflammatory response syndrome in patients with nephrolithiasis.
    Hou YS; Wang H; Chen H; Wu LF; Lu LF; He Y
    Biomed Res Int; 2015; 2015():792572. PubMed ID: 25722986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue.
    Linscheid P; Seboek D; Nylen ES; Langer I; Schlatter M; Becker KL; Keller U; Müller B
    Endocrinology; 2003 Dec; 144(12):5578-84. PubMed ID: 12960010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical usefulness of procalcitonin measurement].
    Kuroda S
    Kansenshogaku Zasshi; 2010 Jul; 84(4):437-40. PubMed ID: 20715553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis?
    Giamarellos-Bourboulis EJ; Giannopoulou P; Grecka P; Voros D; Mandragos K; Giamarellou H
    J Crit Care; 2004 Sep; 19(3):152-7. PubMed ID: 15484175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue.
    Linscheid P; Seboek D; Zulewski H; Keller U; Müller B
    Endocrinology; 2005 Jun; 146(6):2699-708. PubMed ID: 15761041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.